MedTrace Logo

Xience or Vision Stent Management of Angina in the Elderly

NCT02198716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2014-08-15

No results posted yet for this study

Summary

The treatment of complex coronary disease causing limiting symptoms of angina with drug-eluting stent technology will prove superior to bare metal stent technology, with respect to a combined endpoint of mortality, MI, requirement for target vessel revascularisation and severe haemorrhage, in patients aged 80 or above.

Conditions

Interventions

PROCEDURE

Percutaneous Coronary Intervention using drug eluting stents

Percutaneous Coronary Intervention using drug eluting stents

PROCEDURE

Percutaneous Coronary Intervention using bare metal stents

Percutaneous Coronary Intervention using bare metal stents

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Brighton and Sussex University Hospitals NHS Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198716 on ClinicalTrials.gov